HY-100302-1mg
|
MedChemexpress LLC
|
FR183998 free base [CAS 239440-20-1]
|
|
COVID-19-immunoregulation
|
|
HY-100302-10mg
|
MedChemexpress LLC
|
FR183998 free base [CAS 239440-20-1]
|
|
COVID-19-immunoregulation
|
|
HY-100302-100mg
|
MedChemexpress LLC
|
FR183998 free base [CAS 239440-20-1]
|
|
COVID-19-immunoregulation
|
|
HY-100302-25mg
|
MedChemexpress LLC
|
FR183998 free base [CAS 239440-20-1]
|
|
COVID-19-immunoregulation
|
|
HY-100302-5mg
|
MedChemexpress LLC
|
FR183998 free base [CAS 239440-20-1]
|
|
COVID-19-immunoregulation
|
|
HY-100302-50mg
|
MedChemexpress LLC
|
FR183998 free base [CAS 239440-20-1]
|
|
COVID-19-immunoregulation
|
|
HY-116522-10mg
|
MedChemexpress LLC
|
AR420626 [CAS 1798310-55-0]
|
|
|
|
HY-116522-100mg
|
MedChemexpress LLC
|
AR420626 [CAS 1798310-55-0]
|
|
|
|
HY-116522-25mg
|
MedChemexpress LLC
|
AR420626 [CAS 1798310-55-0]
|
|
|
|
HY-116522-5mg
|
MedChemexpress LLC
|
AR420626 [CAS 1798310-55-0]
|
|
|
|
HY-116522-50mg
|
MedChemexpress LLC
|
AR420626 [CAS 1798310-55-0]
|
|
|
|
HY-117743-10mg
|
MedChemexpress LLC
|
Eprosartan [CAS 133040-01-4]
|
|
Neuroscience-Neuromodulation
|
|
HY-117743-5mg
|
MedChemexpress LLC
|
Eprosartan [CAS 133040-01-4]
|
|
Neuroscience-Neuromodulation
|
|
HY-120598-1mg
|
MedChemexpress LLC
|
ASP7657 (free base) [CAS 1196045-28-9]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-125568-500ug
|
MedChemexpress LLC
|
Pyridoxatin [CAS 135529-30-5]
|
|
|
|
HY-19651-1mg
|
MedChemexpress LLC
|
Zanapezil (free base) [CAS 142852-50-4]
|
|
Neuroscience-Neurodegeneration
|
|
HY-19651-10mg
|
MedChemexpress LLC
|
Zanapezil (free base) [CAS 142852-50-4]
|
|
Neuroscience-Neurodegeneration
|
|
HY-19651-5mg
|
MedChemexpress LLC
|
Zanapezil (free base) [CAS 142852-50-4]
|
|
Neuroscience-Neurodegeneration
|
|
HY-19995-10mg
|
MedChemexpress LLC
|
GSK137647A [CAS 349085-82-1]
|
|
Metabolism-sugar/lipid metabolism
|
|
HY-19995-100mg
|
MedChemexpress LLC
|
GSK137647A [CAS 349085-82-1]
|
|
Metabolism-sugar/lipid metabolism
|
|
HY-19995-25mg
|
MedChemexpress LLC
|
GSK137647A [CAS 349085-82-1]
|
|
Metabolism-sugar/lipid metabolism
|
|
HY-19995-5mg
|
MedChemexpress LLC
|
GSK137647A [CAS 349085-82-1]
|
|
Metabolism-sugar/lipid metabolism
|
|
HY-19995-50mg
|
MedChemexpress LLC
|
GSK137647A [CAS 349085-82-1]
|
|
Metabolism-sugar/lipid metabolism
|
|
HY-B1486AS-1mg
|
MedChemexpress LLC
|
Oxprenolol-d7 [CAS 1189805-10-4]
|
|
|
|
HY-W127391-10mg
|
MedChemexpress LLC
|
1,2-Dilaurin [CAS 17598-94-6]
|
|
|
|